Michael Zöller
Impact in
-
- Antibiotic Use and Resistance
- Pharmacology top 1%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
- Pharmacology 25
- Antibiotics Pharmacokinetics and Efficacy 25
- Epidemiology 18
- Pneumonia and Respiratory Infections 7
- Cytomegalovirus and herpesvirus research 4
- Co-authors
- Christina Scharf (43 shared papers)Michael Vogeser (24 shared papers)Michael Paal (24 shared papers)Johannes Zander (20 shared papers)Uwe Liebchen (32 shared papers)Ines Schroeder (22 shared papers)Lorenz Frey (11 shared papers)Michael Irlbeck (18 shared papers)
- Journals
- Critical Care (5 papers)Antimicrobial Agents and Chemotherapy (5 papers)Annals of Intensive Care (4 papers)Journal of Critical Care (4 papers)Journal of Antimicrobial Chemotherapy (3 papers)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Michael Zöller
80 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 107
- Applied Microbiology and Biotechnology 99
- Pharmacology 616
- Molecular Medicine 176
- Critical Care and Intensive Care Medicine 64
- Infectious Diseases 244
Countries citing papers authored by Michael Zöller
This map shows the geographic impact of Michael Zöller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Zöller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Zöller more than expected).
Fields of papers citing papers by Michael Zöller
This network shows the impact of papers produced by Michael Zöller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Zöller. The network helps show where Michael Zöller may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Zöller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 91 | |
| 2 | 2014 | 77 | |
| 3 | 2018 | 64 | |
| 4 | 2006 | 63 | |
| 5 | 2021 | 59 | |
| 6 | 2017 | 58 | |
| 7 | 2019 | 56 | |
| 8 | 2020 | 49 | |
| 9 | 2016 | 49 | |
| 10 | 2019 | 47 | |
| 11 | 2016 | 46 | |
| 12 | 2020 | 43 | |
| 13 | 2021 | 42 | |
| 14 | Thyroglossal duct carcinoma. | 1994 | 42 |
| 15 | 2021 | 38 | |
| 16 | 2015 | 36 | |
| 17 | 2020 | 36 | |
| 18 | 2020 | 30 | |
| 19 | 2017 | 28 | |
| 20 | 2019 | 27 |
About Michael Zöller
Michael Zöller is a scholar working on Pharmacology, Epidemiology, Infectious Diseases, Surgery and Critical Care and Intensive Care Medicine, having authored 85 papers that have together received 1.5k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (25 papers), Pneumonia and Respiratory Infections (7 papers), Intensive Care Unit Cognitive Disorders (6 papers), Antibiotic Use and Resistance (6 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Antifungal resistance and susceptibility (4 papers), Cytomegalovirus and herpesvirus research (4 papers) and Muscle and Compartmental Disorders (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (99 citations), Pharmacology (616 citations), Molecular Medicine (176 citations), Critical Care and Intensive Care Medicine (64 citations) and Infectious Diseases (244 citations). Michael Zöller has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Christina Scharf, Michael Vogeser, Michael Paal, Johannes Zander, Uwe Liebchen, Ines Schroeder, Lorenz Frey, Michael Irlbeck, Bárbara Maier and Daniel Teupser. Their work appears in journals such as Critical Care, Antimicrobial Agents and Chemotherapy, Annals of Intensive Care, Journal of Critical Care and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.